EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Neogen's enterprise value is $3,351.3 Mil.
Neogen's EBITDA for the trailing twelve months (TTM) ended in Feb. 2024 was $188.8 Mil. Therefore, Neogen's EV-to-EBITDA for today is 17.75.
The historical rank and industry rank for Neogen's EV-to-EBITDA or its related term are showing as below:
NEOG'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 12.21 Med: 32.54 Max: 79.64
Current: 17.75
During the past 13 years, the highest EV-to-EBITDA of Neogen was 79.64. The lowest was 12.21. And the median was 32.54.
NEOG's EV-to-EBITDA is ranked worse than 65% of 120
companies
in the Medical Diagnostics & Research industry
Industry Median: 15.16
vs NEOG: 17.75
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-04-18), Neogen's stock price is $11.93.
Neogen's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 was $0.006. Therefore, Neogen's PE Ratio for today is 1,988.33.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Neogen EV-to-EBITDA Historical Data
The historical data trend for Neogen's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Neogen Annual Data
Trend
May14
May15
May16
May17
May18
May19
May20
May21
May22
May23
EV-to-EBITDA
31.21
39.89
47.51
29.43
36.16
Neogen Quarterly Data
May19
Aug19
Nov19
Feb20
May20
Aug20
Nov20
Feb21
May21
Aug21
Nov21
Feb22
May22
Aug22
Nov22
Feb23
May23
Aug23
Nov23
Feb24
EV-to-EBITDA
48.65
36.16
35.59
22.89
23.55
Competitive Comparison
For the Diagnostics & Research subindustry, Neogen's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Neogen EV-to-EBITDA Distribution
For the Medical Diagnostics & Research industry and Healthcare sector, Neogen's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Neogen's EV-to-EBITDA falls into.
Neogen's current Enterprise Value is $3,351.3 Mil.
Neogen's EBITDA for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $188.8 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Neogen (NAS:NEOG) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Neogen's share price for today is $11.93.
Neogen's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.006.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Neogen's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety (70% of post-merger sales), Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety (20% of post-merger sales), Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for 60% of total revenue, while international markets, including Canada, Europe, Asia, and Latin America, account for the remaining 40%.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NEOG has been successfully added to your 